Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdivo® (nivolumab) in Advanced Solid Tumors

Antengene Announces Clinical Collaboration With Bristol Myers Squibb To Evaluate Atg 017 In Combination With Opdivo® (nivolumab) In Advanced Solid Tumors

Facebook Comments

Leave a Reply

CommentLuv badge